Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Resonance Health Ltd ( (AU:RHT) ) just unveiled an update.
Resonance Health Ltd has released updated shareholder information in compliance with ASX Listing Rule 4.10. This update includes details on corporate governance, securities distribution, and the top twenty security holders. The announcement replaces previous shareholder information from the company’s annual report and reflects the company’s commitment to transparency and regulatory compliance.
More about Resonance Health Ltd
Resonance Health is an Australian healthcare technology and services company that provides globally recognized quantitative assessments for managing human diseases. The company offers Software-as-Medical Devices (SaMDs) that have received regulatory clearances in the USA, Europe, UK, and Australia. Their products, which include FerriScan®, FerriSmart®, HepaFatScan®, HepaFatSmart®, LiverSmart®, and CardiacT2*, are used in clinical trials and endorsed by leading physicians worldwide.
Average Trading Volume: 358,270
Technical Sentiment Signal: Sell
Current Market Cap: A$18.36M
For detailed information about RHT stock, go to TipRanks’ Stock Analysis page.